tbuckley/cabot-search huggingface dataset:
THE MASSACHUSETTS GENERAL HOSPITAL.
Journal: JAMA (1900)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The 1948 Year Book of General Therapeutics
Journal: JAMA (1949)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Decreased Susceptibility of Neisseria gonorrhoeae to Fluoroquinolones—Ohio and Hawaii, 1992-1994
Journal: JAMA (1994)

Until 1992, virtually all strains of N. gonorrhoeae tested were susceptible to fluoroquinolones, including ciprofloxacin (minimal inhibitory concentrations [MICs] of < or = 0.06 microgram/mL). However, gonococcal strains with decreased susceptibilities to ciprofloxacin (MICs of 0.13-0.25 micrograms/mL) have been isolated sporadically from patients in the United States through the Gonococcal Isolate Surveillance Project (GISP), which measures antimicrobial susceptibilities of urethral isolates from men each month. This report describes findings from Ohio and Hawaii that suggest the emergence of fluoroquinolone resistance in N. gonorrhoeae.
TCT-170 Development and Validation of a Scoring System for Predicting Clinical Coronary Artery Perforation During Percutaneous Coronary Interventions of Chronic Total Occlusions: The PROGRESS-CTO Perforation Score
Authors: Spyridon Kostantinis, Bahadir Simsek, Judit Karacsonyi, Khaldoon Alaswad, Farouc Jaffer, Jaikirshan Khatri, James Choi, Wissam Jaber, Stephane Rinfret, William Nicholson, Mitul Patel, Ehtisham Mahmud, Catalin Toma, Rhian Davies, Jimmy Kerrigan, Elias Haddad, Sevket Gorgulu, Ahmed ElGuindy, Omer Goktekin, Salman Allana, M. Nicholas Burke, Olga Mastrodemos, Bavana Rangan, Emmanouil Brilakis
Journal: Journal of the American College of Cardiology (2022)
TCT-159 Percutaneous Coronary Intervention of Large Coronary Vessels With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 4.5/5.0 mm Stent: Primary Outcomes of the EVOLVE Large Vessel Study
Authors: Robert Stoler, Frances Wood, Zafir Hawa, Steven Rudick, Punag Divanji, Robert Yeh, Bernardo Stein, Wayne Batchelor, Elissa Altin, Paul Underwood, Dominic Allocco
Journal: Journal of the American College of Cardiology (2022)
TCT-176 Randomized Comparison of Intracoronary Lithotripsy and Rotational Atherectomy for the Treatment of Severely Calcified Vessels—ROTA.shock Trial
Authors: Holger Nef, Sophia Schlattner, Melissa Weissner, Tommaso Gori, Helen Ullrich, Luise Gaede, Stephan Achenbach, Helge Möllmann, Johannes Blumenstein, Adem Aksoy, Georg Nickenig, Maren Weferling, Oliver Dörr, Niklas Boeder, Matthias Bayer, Christian Hamm, Florian Blachutzik
Journal: Journal of the American College of Cardiology (2022)
Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells
Authors: Lynsey M. Whilding, Ana C. Parente-Pereira, Tomasz Zabinski, David M. Davies, Roseanna M.G. Petrovic, Y. Vincent Kao, Shobhit A. Saxena, Alex Romain, Jose A. Costa-Guerra, Shelia Violette, Hiroaki Itamochi, Sadaf Ghaem-Maghami, Sabari Vallath, John F. Marshall, John Maher
Journal: Molecular Therapy (2017)

Expression of the αvβ6 integrin is upregulated in several solid tumors. In contrast, physiologic expression of this epithelial-specific integrin is restricted to development and epithelial re-modeling. Here, we describe, for the first time, the development of a chimeric antigen receptor (CAR) that couples the recognition of this integrin to the delivery of potent therapeutic activity in a diverse repertoire of solid tumor models. Highly selective targeting αvβ6 was achieved using a foot and mouth disease virus-derived A20 peptide, coupled to a fused CD28+CD3 endodomain. To achieve selective expansion of CAR T cells ex vivo, an IL-4-responsive fusion gene (4αβ) was co-expressed, which delivers a selective mitogenic signal to engineered T cells only. In vivo efficacy was demonstrated in mice with established ovarian, breast, and pancreatic tumor xenografts, all of which express αvβ6 at intermediate to high levels. SCID beige mice were used for these studies because they are susceptible to cytokine release syndrome, unlike more immune-compromised strains. Nonetheless, although the CAR also engages mouse αvβ6, mild and reversible toxicity was only observed when supra-therapeutic doses of CAR T cells were administered parenterally. These data support the clinical evaluation of αvβ6 re-targeted CAR T cell immunotherapy in solid tumors that express this integrin. Expression of the αvβ6 integrin is upregulated in several solid tumors. In contrast, physiologic expression of this epithelial-specific integrin is restricted to development and epithelial re-modeling. Here, we describe, for the first time, the development of a chimeric antigen receptor (CAR) that couples the recognition of this integrin to the delivery of potent therapeutic activity in a diverse repertoire of solid tumor models. Highly selective targeting αvβ6 was achieved using a foot and mouth disease virus-derived A20 peptide, coupled to a fused CD28+CD3 endodomain. To achieve selective expansion of CAR T cells ex vivo, an IL-4-responsive fusion gene (4αβ) was co-expressed, which delivers a selective mitogenic signal to engineered T cells only. In vivo efficacy was demonstrated in mice with established ovarian, breast, and pancreatic tumor xenografts, all of which express αvβ6 at intermediate to high levels. SCID beige mice were used for these studies because they are susceptible to cytokine release syndrome, unlike more immune-compromised strains. Nonetheless, although the CAR also engages mouse αvβ6, mild and reversible toxicity was only observed when supra-therapeutic doses of CAR T cells were administered parenterally. These data support the clinical evaluation of αvβ6 re-targeted CAR T cell immunotherapy in solid tumors that express this integrin.
Advisory Board and Contents
Authors: Cristian Polo, Tom Deegan, Bing Xiao, Pei Li, Qingyu Wu, Chen-Shiou Wu, Wen-Hsin Lu, Mien-Chie Hung, Yi-Shuian Huang, Hsu-Wen Chao, Kevin Brindle, Mengqi Li, Ruiping Tian, David Monchaud, Wenli Zhang, Cornille Amandine, Dieter Ebert, Eva Stukenbrock, Ricardo Rodríguez De La Vega, Peter Tiffi, Daniel Croll, Aurélien Tellier
Journal: Trends in Genetics (2022)
LICENSURE OF GRADUATES OF FOREIGN MEDICAL SCHOOLS
Journal: JAMA (1952)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Apparent Failures of Endocarditis Prophylaxis
Authors: David T. Durack
Journal: JAMA (1983)

Fifty-two cases of apparent endocarditis prophylaxis failure were reported to a national registry established by the American Heart Association (AHA). Mitral valve prolapse was the single most common underlying cardiac lesion (17 cases, 33%), followed by various congenital abnormalities (15 cases, 29%) and rheumatic heart disease (11 cases, 21%). Ten patients (19%) had prosthetic valve endocarditis. Forty-eight cases (92%) occurred after a dental procedure. Symptoms began within two weeks after the procedure suspected to have caused endocarditis in 50% and within five weeks in 79%. Thirty-nine cases (75%) were caused by viridans streptococci and seven (14%) by<i>Staphylococcus aureus</i>. Most patients received oral penicillin as prophylaxis. Only six patients (12%) received regimens currently recommended by the AHA. In 27 (63%) of the 43 cases for which antimicrobial susceptibility data were available, the infecting microorganism was sensitive to the antibiotic(s) used for prophylaxis. After diagnosis of endocarditis, the prognosis for bacteriologic cure was good; 47 patients (90%) were cured, of whom seven underwent valve replacement. These data indicate that endocarditis prophylaxis failures may be more common than was previously believed and that failures occur even when the infecting organism is susceptible to the antibiotics used. Most antimicrobial regimens used in patients with prophylaxis failures did not conform to current recommendations. (<i>JAMA</i>1983;250:2318-2322)
Does This Patient Have Sinusitis?
Authors: John W. Williams
Journal: JAMA (1993)

<h3>DOES THIS PATIENT HAVE SINUSITIS?</h3><h3>Clinical Scenario</h3> The patient presents to your office with a "bad cold." Her symptoms began 5 days ago when a runny nose, a scratchy throat, generalized malaise, and a nonproductive cough developed. Her symptoms are gradually improving with an over-the-counter cough medicine, but during the past 24 hours a "sinus headache" has developed. The patient is concerned that she may have "sinus." Of note, it is the middle of "cold and flu" season, and this is the fifth patient you've seen today with upper respiratory-tract symptoms. <h3>Why Is This an Important Question to Answer With a Clinical Examination?</h3> The patient's story is familiar to primary care clinicians. Indeed, the most frequent diagnoses made by primary care practitioners include nasal problems such as allergic and infectious rhinitis, vasomotor rhinitis, and bacterial sinusitis.<sup>1</sup>Given the constant assault of allergens, environmental pollutants, respiratory viruses, and rapid temperature
522MO Preliminary results of sintilimab (Sin)+bevacizumab (Bev) in recurrent/persistent ovarian clear cell carcinoma (INOVA): A multicenter, single-arm, phase II trial
Authors: X. Liu, B. Xia, W. Zhang, L. Sun, C. Feng, Y. Huang, Y. Gao, J. Jiang, G. Li, Q. Gao
Journal: Annals of Oncology (2022)
529MO Phase II study of olaparib plus durvalumab with or without bevacizumab (MEDIOLA): Final analysis of overall survival in patients with non-germline BRCA-mutated platinum-sensitive relapsed ovarian cancer
Authors: S. Banerjee, M. Imbimbo, P. Roxburgh, J-W. Kim, M.H. Kim, R. Plummer, S. Stemmer, B. You, M. Ferguson, R.T. Penson, D. O'Malley, K. Meyer, H. Gao, H. Angell, A. Tablante Nunes, S. Domchek, Y. Drew
Journal: Annals of Oncology (2022)
Modern Microscopy. A Handbook for Beginners and Students.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Authors: Yumeko Kawano, Naomi J Patel, Xiaosong Wang, Claire E Cook, Kathleen MM Vanni, Emily N Kowalski, Emily P Banasiak, Grace Qian, Michael DiIorio, Tiffany Y-T Hsu, Michael E Weinblatt, Derrick J Todd, Zachary S Wallace, Jeffrey A Sparks
Journal: Annals of the Rheumatic Diseases (2022)

To investigate temporal trends in incidence and severity of COVID-19 among patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave through the initial Omicron wave.We conducted a retrospective cohort study investigating COVID-19 outcomes among patientswith SARD systematically identified to have confirmed COVID-19 from 1 March 2020 to 31 January 2022 at Mass General Brigham. We tabulated COVID-19 counts of total and severe cases (hospitalisations or deaths) and compared the proportion with severe COVID-19 by calendar period and by vaccination status. We used logistic regression to estimate the ORs for severe COVID-19 for each period compared with the early COVID-19 period (reference group).We identified 1449 patients with SARD with COVID-19 (mean age 58.4 years, 75.2% female, 33.9% rheumatoid arthritis). There were 399 (28%) cases of severe COVID-19. The proportion of severe COVID-19 outcomes declined over calendar time (p for trend <0.001); 46% of cases were severe in the early COVID-19 period (1 March 2020-30 June 2020) vs 15% in the initial Omicron wave (17 December 2021-31 January 2022; adjusted OR 0.29, 95% CI 0.19 to 0.43). A higher proportion of those unvaccinated were severe compared with not severe cases (78% vs 60%).The proportion of patients with SARD with severe COVID-19 has diminished since early in the pandemic, particularly during the most recent time periods, including the initial Omicron wave. Advances in prevention, diagnosis and treatment of COVID-19 may have improved outcomes among patients with SARD.
KOOS-Child exhibits inadequate structural validity in a cohort of paediatric patients with ACL deficiency
Authors: Christian Fugl Hansen, Maria Østergaard Madsen, Susan Warming, Martin Wyman Rathcke, Michael Krogsgaard, Karl Bang Christensen
Journal: British Journal of Sports Medicine (2022)

Knee injury and Osteoarthritis Outcome Score (KOOS)-Child is a modification of the adult KOOS aiming to evaluate knee injury, including ACL deficiency. However, the measurement properties of KOOS-Child have not been assessed in a cohort of children with ACL deficiency. We aimed to study the structure of KOOS-Child using modern test theory models (Rasch analysis and confirmatory factor analysis (CFA)).Data were collected prospectively in a cohort of children with ACL deficiency at three time points: before-and-after ACL surgery, and at 1-year follow-up. For each subscale, structural validity through the fit of a CFA model was evaluated for 153 respondents. Modification indices were examined to find the model of best fit, confirmed using Rasch analysis. Responsiveness was reported for each subscale. Reliability was calculated for each item. Floor and ceiling effects, and Person-item distribution were reported.All subscales showed inadequate fit to a unidimensional CFA model. Rasch analysis confirmed these results. Adjusting the subscales improved model fit, although this was still quite poor, except for the quality of life subscale. With one exception, all items demonstrated ceiling effects. Person-item distribution confirmed this. Due to lack of fit, reliability was not reported. All subscales were able to detect change from baseline to 1-year follow-up.KOOS-Child exhibits inadequate measurement properties in its current form for children with ACL deficiency. Suggestions to make the subscales fit the models better and improve accuracy of KOOS-Child are presented. However, the large ceiling effects observed may reduce sensitivity and induce type 2 errors.
TCT-549 Impact of COVID-19 Pandemic on TAVR Activity: A Worldwide Registry
Authors: Xavier Armario, Jennifer Carron, Mohamed Abdel-Wahab, Didier Tchetche, Sabine Bleiziffer, Thierry Lefevre, Thomas Modine, Alexander Wolf, Thomas Pilgrim, Pedro Villablanca, Michael Cunnington, Nicolas Van Mieghem, Christian Hengstenberg, Lars Sondergaard, Martin Swaans, Bernard Prendergast, Marco Barbanti, John Webb, Neal Uren, Jon Resar, Mao Chen, David Hildick-Smith, Mark Spence, David Zweiker, Rodrigo Bagur, Hospital de Cruz, Flavio Ribichini, Duk-Woo Park, Pablo Codner, Joanna Wykrzykowska, Matjaz Bunc, Rodrigo Estevez-Loureiro, Karl Poon, Matthias Götberg, Hüseyin Ince, Azeem Latib, Erik Packer, Marco Angelillis, Yusuke Kobari, Luis Nombela-Franco, Yingqiang Guo, Mikko Savontaus, Amr A. Arafat, Chad Kliger, David Roy, Béla Merkely, Mariana Silva, Jonathon White, Masanori Yamamoto, Pedro Carrilho Ferreira, Stefan Toggweiler, Yohei Ohno, Ines Rodrigues, Soledad Ojeda, Vasileios Voudris, Marek Grygier, Khaled Almerri, Ignacio Cruz-Gonzalez, Viliam Fridrich, Jose De la Torre Hernandez, Nicolo Piazza, Stephane Noble, Dabit Arzamendi, None İbrahim halil Kurt, Johan Bosmans, Martins Erglis, Ivan Casserly, Fadi Sawaya, Ravinay Bhindi, Joelle Kefer, Wei-Hsian Yin, Liesbeth Rosseel, Hyo-Soo Kim, Stephen O'Connor, Farrel Hellig, Matias Sztejfman, Oscar Mendiz, Robert Xuereb, Fabio Brito Jr, Vilhelmas Bajoras, Mohammed Balghith, Michael Kang-Yin Lee, Guering Eid-Lidt, Bert Vandeloo, Vinicius Vaz, Mirvat Alasnag, Gian Paolo Ussia, Jorge Mayol, Gennaro Sardella, Wacin Buddhari, Hsien-Li Kao, Antonio Dager, Apostolos Tzikas, Ahmad Edris, Luis Gutierrez, Eduardo Arias, Mehmet Erturk, César Nicolás Conde Vela, Darko Boljevic, Adolfo Ferrero Guadagnoli, Ahmed ElGuindy, Luciano Santos, Luis Perez, Gabriel Maluenda, Ali Rıza Akyüz, Imad Alhaddad, Haitham Amin, So Chak Yu, Arif Alnooryani, Juan Albistur, Quang Nguyen, Darren Mylotte
Journal: Journal of the American College of Cardiology (2022)
Indocyanine Green Clearance as a Test for Hepatic Function
Authors: Carroll M. Leevy
Journal: JAMA (1967)

A study of clearance of dyes which are removed from the circulation principally by the liver constitutes one of the best methods for evaluating hepatic function. This approach has not been widely used because of the need for multiple blood sampling to calculate accurately removal rate of sulf obromophthalein (BSP) and for radioisotope-counting equipment for clearance studies of rose bengal I 131.<sup>1</sup>These disadvantages are largely overcome by indocyanine green (ICG), which possesses physical properties which permit external recording of blood dye levels. The major limitation of ICG has been the fact that, in doses conventionally used, it has proven much less sensitive than BSP in detecting mild liver-cell damage<sup>2</sup>or demonstrating the excretory defect produced by synthetic androgenicanabolic steroids.<sup>3</sup> Levels of ICG have been recorded by use of an air-cooled oximeter to measure light transmission<sup>4</sup>or electric eye to determine light reflection.<sup>5</sup>Accuracy of
Diagnosis of Secondary Forms of Hypertension
Authors: Clarence E. Grim
Journal: JAMA (1977)

An efficient protocol for the evaluation of hypertensive cases included renal arteriography, suppression and stimulation of the renin-aldosterone system, and, when indicated, renal venous renin measurements. It permitted identification of 38 patients with renal artery stenosis, 28 with primary aldosteronism, and 51 with high renin, 92 with normal renin, and 27 with low renin essential hypertension. (<i>JAMA</i>237:1331-1335, 1977)
Noninvasive Testing vs Clinical Evaluation of Arterial Disease
Authors: Michael R. Marinelli
Journal: JAMA (1979)

In a prospective clinical study involving 458 diabetic patients, the results of noninvasive testing procedures were compared with the findings obtained by clinical evaluation. The results of the study showed that nearly one third of the patients who gave no history of intermittent claudication were found to have arterial disease when tested. One fifth of the patients with what were considered normal physical examination results had abnormal results by noninvasive testing. When history and physical examination prove ineffective for obtaining a diagnosis of arterial disease, the use of noninvasive devices effectively rules out or confirms the presence of hemodynamically significant arterial obstruction. Not only can simple, noninvasive testing methods greatly increase the accuracy of clinical diagnosis for the presence of arterial disease, but the baseline data obtained can serve as objective indexes to follow the natural history of the disease. (<i>JAMA</i>241:2031-2034, 1979)
TCT-198 Differential Improvement in Angina and Health-Related Quality of Life After Percutaneous Coronary Interventions in Focal and Diffuse Coronary Artery Disease
Authors: Takuya Mizukami, Carlos Collet, Damien Collison, Peter McCartney, Jeroen Sonck, Tom Ford, Daniel Munhoz, Colin Berry, Bernard De Bruyne, Keith Oldroyd
Journal: Journal of the American College of Cardiology (2022)
TCT-202 Pre-Ballooning in High Thrombus Laden STEMIs: An Independent Predictor of Slow Flow/No-Reflow in Patients Undergoing Emergent Percutaneous Coronary Revascularization
Authors: Dr.Rajesh Kumar, Nadeem Qamar, Tahir Saghir, Jawaid Sial, Ali Ammar, Musa Karim, Ashok Kumar
Journal: Journal of the American College of Cardiology (2022)